World news, news around town, tech update 3
Ad
Friday, 22 December 2017
Roche to buy U.S. cancer drugmaker Ignyta for $1.7 billion
(Reuters) - Swiss drugmaker Roche will buy U.S. cancer drugmaker Ignyta Inc for $1.7 billion to broaden its oncology portfolio globally, the companies said on Friday.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment